Ardelyx, Inc. (ARDX) vs Immix Biopharma, Inc. (IMMX)
Ardelyx, Inc. and Immix Biopharma, Inc. are both Biotechnology companies. Ardelyx, Inc. and Immix Biopharma, Inc. are of similar size ($859.7M and $844.3M). Immix Biopharma, Inc. has the higher net margin (0.00% vs −12.4%) and the higher return on invested capital (0.00% vs −18.6%). Across the 13 metrics below, Immix Biopharma, Inc. leads on 9 and Ardelyx, Inc. on 4.
Valuation
Profitability
| Metric | ARDX | IMMX | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.37% | — | 65.16% |
| Operating margin | (7.86%) | 0.00% | 0.00% |
| Net margin | (12.35%) | 0.00% | 0.00% |
| Free cash flow margin | (3.97%) | 0.00% | 0.00% |
| Return on equity | (38.61%) | (34.18%) | (57.72%) |
| Return on assets | (10.68%) | (31.34%) | (49.22%) |
| Return on invested capital | (18.62%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack